Genomics tool developer 10x Genomics has raised $35m that will be combined with the $50m SoftBank-backed first close it achieved in April.

Hill-Rom and Wells Fargo have co-led the medical monitoring device maker's latest round, taking its total funding to almost $140m.

The Cisco and Deutsche Telekom-backed video advertising software provider has received capital from Goldman Sachs that it described as pre-IPO funding.

NantCell received the funding at a $4bn valuation, giving existing investor Celgene a 2.8% stake in the cancer immunotherapy developer.

Celgene and Evotec both invested in Exscientia, as the automated drug discovery services provider added Roche to its roster of development partners.

Unilever was among the existing investors that supplied $22.9m for meal kit provider Gousto, increasing its funding to about $100m to date.

Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer's series B round to $35.9m, following a Novartis-led tranche a year ago.

Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.

Lundbeckfonden Ventures and Alexandria Venture Investments both backed a series A round for tumour and endocrine disease drug developer Tiburio.

Alexandria Venture Investments has taken part in the final close of the series B round, which will fund development of the company's cell therapy platform.